Prognostic role of microRNA-21 expression in gliomas: a meta-analysis

Journal of Neuro-Oncology

Volumn 130, Issue 1, 2016, Pages 11-17

  Li, Chao ^a   Sun, Jianjun ^a   Xiang, Qian ^a   Liang, Yan ^a   Zhao, Nan ^a   Zhang, Zhuo ^a   Liu, Qianxin ^a   Cui, Yimin ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Glioblastomas; Glioma; mir 21

Indexed keywords

MICRORNA 21; TUMOR MARKER; MICRORNA; MIRN21 MICRORNA, HUMAN;

CANCER GROWTH; CANCER PROGNOSIS; EMBASE; GENE EXPRESSION; GLIOBLASTOMA; GLIOMA; HUMAN; INFORMATION RETRIEVAL; KARNOFSKY PERFORMANCE STATUS; MEDLINE; META ANALYSIS (TOPIC); OVERALL SURVIVAL; PREDICTIVE VALUE; REVIEW; SAMPLE SIZE; WEB OF SCIENCE; BIBLIOGRAPHIC DATABASE; BRAIN TUMOR; GENETICS; META ANALYSIS; METABOLISM; MORTALITY; PROGNOSIS; STATISTICS AND NUMERICAL DATA;

BRAIN NEOPLASMS; DATABASES, BIBLIOGRAPHIC; GLIOBLASTOMA; GLIOMA; HUMANS; KARNOFSKY PERFORMANCE STATUS; MICRORNAS; PROGNOSIS;

EID: 84982108607     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-016-2233-7     Document Type: Review

References (52)

1. Goodenberger ML, Jenkins RB (2012) Genetics of adult glioma. Cancer Genet 205(12):613–621
2. Dolecek TA, Propp JM, Stroup NE et al (2012) CBTRUS statistical report: primary brain andcentral nervous system tumors diagnosed in the United States in 2005–2009. Neuro Oncol. doi:10.1093/neuonc/nos218
3. van den Bent MJ, Kros JM (2007) Predictive and prognostic markers in neuro-oncology. J Neuropathol Exp Neurol 66(12):1074–1081
4. Dellaretti M, Reyns N, Touzet G et al (2012) Diffuse brainstem glioma: prognostic factors: clinical article. J Neurosurg.117(5):810–814
5. Johnson DR, Galanis E (2013) Incorporation of prognostic and predictive factors into glioma clinical trials. Curr Oncol Rep 15(1):56–63
6. Kwak HJ, Kim YJ, Chun KR et al (2011) Downregulation of Spry2 by miR-21 triggers malignancy in human gliomas. Oncogene 30(21):2433–2442
7. Li WQ, Yu HY, Li YM et al (2014) Higher LRRFIP1 expression in glioblastoma multiforme is associated with better response to teniposide, a type II topoisomerase inhibitor. Biochem Biophys Res Commun 446(4):1261–1267
8. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281–297
9. Lim LP, Lau NC, Garrett-Engele P et al (2005) Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433(7027):769–773
10. Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6(11):857–866
11. Nana-Sinkam P, Croce CM (2010) MicroRNAs in diagnosis and prognosis in cancer: what does the future hold? Pharmacogenomics 11(5):667–669
12. Krichevsky AM, Gabriely G (2009) MiR-21: a small multi-faceted RNA. J Cell Mol Med 13(1):39–53
13. Volinia S, Calin GA, Liu CG et al (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA. 103(7):2257–2261
14. Hatley ME, Patrick DM, Garcia MR et al (2010) Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. Cancer Cell 18(3):282–293
15. Chan JA, Krichevsky AM, Kosik KS (2005) MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65(14):6029–6033
16. Folini M, Gandellini P, Longoni N et al (2010) MiR-21: an oncomir on strike in prostate cancer. Mol Cancer 9:12
17. Conti A, Aguennouz M, La Torre D et al (2009) miR-21 and 221 upregulation and miR-181b downregulation in human grade II–IV astrocytic tumors. J Neurooncol 93(3):325–332
18. Ho CY, Bar E, Giannini C, Marchionni L et al (2013) MicroRNA profiling in pediatric pilocytic astrocytoma reveals biologically relevant targets, including PBX3, NFIB, and METAP2. Neuro Oncol 15(1):69–82
19. Barbano R, Palumbo O, Pasculli B et al (2014) A miRNA signature for defining aggressive phenotype and prognosis in gliomas. PLoS One 9(10):e108950
20. Hermansen SK, Dahlrot RH, Nielsen BS et al (2013) MiR-21 expression in the tumor cell compartment holds unfavorable prognostic value in gliomas. J Neurooncol 111(1):71–81
21. Childs G, Fazzari M, Kung G, Kawachi N et al (2009) Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. Am J Pathol 174(3):736–745
22. Heneghan HM, Miller N, Kelly R et al (2010) Systemic miRNA-195 differentiates breast cancer from other malignancies and is a potential biomarker for detecting noninvasive and early stage disease. Oncologist 15(7):673–682
23. Song J, Bai Z, Zhang J et al (2013) Serum microRNA-21 levels are related to tumor size in gastric cancer patients but cannot predict prognosis. Oncol Lett 6:1733–1737
24. Li G, Zhang Z, Tu Y et al (2013) Correlation of microRNA-372 up regulation with poor prognosis in human glioma. Diagn Pathol 8:1
25. Maachani UB, Tandle A, Shankavaram U et al (2015) Modulation of miR-21 signaling by MPS1 in human glioblastoma. Oncotarget. doi:10.18632/oncotarget.4143
26. Wu L, Li G, Feng D, Qin H et al (2013) MicroRNA-21 expression is associated with overall survival in patients with glioma. Diagn Pathol 8:200
27. Stroup DF, Berlin JA, Morton SC et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (moose) group. JAMA 283:2008–2012
28. Tierney JF, Stewart LA, Ghersi D et al (2007) Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 8:16
29. Zhi F, Chen X, Wang S et al (2010) The use of hsa-miR-21, hsa-miR-181b and hsa-miR-106a as prognostic indicators of astrocytoma. Eur J Cancer 46(9):1640–1649
30. Shi R, Wang PY, Li XY et al (2015) Exosomal levels of miRNA-21 from cerebrospinal fluids associated with poor prognosis and tumor recurrence of glioma patients. Oncotarget 6(29):26971–81
31. Louis DN, Ohgaki H, Wiestler OD et al. (2007) WHO classification of tumours of the central nervous system, 4th edn. International Agency for Research on Cancer (IARC), Lyon
32. Xia X, Yang B, Zhai X et al (2013) Prognostic role of microRNA-21 in colorectal cancer: a meta-analysis. PLoS One 8(11):e80426
33. Yan LX, Huang XF, Shao Q et al (2008) MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA 14(11):2348–2360
34. Zhang JG, Wang JJ, Zhao F et al (2010) MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC). Clin Chim Acta 411:846–852
35. Lu Z, Liu M, Stribinskis V et al (2008) MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene 27(31):4373–4379
36. Meng F, Henson R, Wehbe-Janek H et al (2007) MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133(2):647–658
37. Zhu S, Si ML, Wu H et al (2007) MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 282(19):14328–14336
38. Papagiannakopoulos T, Shapiro A, Kosik KS (2008) MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res 68(19): 8164–8172
39. Song B, Wang C, Liu J et al (2010) MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression. J Exp Clin Cancer Res 29:29
40. Sarkar J, Gou D, Turaka P et al (2010) MicroRNA-21 plays a role in hypoxia-mediated pulmonary artery smooth muscle cell proliferation and migration. Am J Physiol Lung Cell Mol Physiol 299(6):L861–L871
41. Iliopoulos D, Jaeger SA, Hirsch HA et al (2010) STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol Cell 39(4):493–506
42. Dong Y, Sui L, Yamaguchi F et al (2010) Phosphatase and tensin homolog deleted on chromosome 10 regulates sensory cell proliferation and differentiation of hair bundles in the mammalian cochlea. Neuroscience 170(4):1304–1313
43. Gao Q, Zhang L, Zhang B et al (2014) Phosphatase and tensin homolog overexpression decreases proliferation and invasion and increases apoptosis in oral squamous cell carcinoma cells. Oncol Lett 8(3):1058–1064
44. Peters JM, Aoyama T, Cattley RC et al (1998) Role of peroxisome proliferator-activated receptor alpha in altered cell cycle regulation in mouse liver. Carcinogenesis 19(11):1989–1994
45. Gabriely G, Wurdinger T, Kesari S et al (2008 Sep) MicroRNA-21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol Cell Biol 28(17):5369–5380
46. Gu L, Li H, Chen L, Ma X et al (2015) MicroRNAs as prognostic molecular signatures in renal cell carcinoma: a systematic review and meta-analysis. Oncotarget 6(32):32545–32560
47. Wang Y, Zhang Y, Pan C et al (2015) Prediction of poor prognosis in breast cancer patients based on microRNA-21 expression: a meta-analysis. PLoS One 10(2):e0118647
48. Fu C, Dong W, Wang Z et al (2014) The expression of miR-21 and miR-375 predict prognosis of esophageal cancer. Biochem Biophys Res Commun 446(4):1197–1203
49. Xia XC, Yang BX, Zhai XG et al (2013) Prognostic role of microRNA-21 in colorectal cancer: a meta-analysis. Plos One 8:e80426
50. Hayes DF, Isaacs C, Stearns V (2001) Prognostic factors in breast cancer: current and new predictors of metastasis. J Mammary Gland Biol Neoplasia 6:375–392
51. Huang RS, Gamazon ER, Ziliak D et al (2011) Population differences in microRNA expression and biological implications. Rna Biol 8:692–701
52. Bleeker FE, Molenaar RJ, Leenstra S (2012) Recent advances in the molecular understanding of glioblastoma. J Neurooncol 108(1):11–27